Search Results 71-80 of 17101 for nivolumab

  1. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment. Participation ...

  2. Melanoma Clinical Trials - Mayo Clinic Research

    ... nivolumab versus nivolumab monotherapy in subjects with unresectable or metastatic melanoma. The primary objective of Phase 3 is to evaluate progression ...

  3. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

    The purpose of the dose escalation phase is to establish the Phase 3 dose of indoximod in combination with pembrolizumab or nivolumab in subjects with ...

  4. A Study Of Brentuximab Vedotin Combined With Nivolumab For Relapsed Or Refractory Hodgkin Lymphoma - Mayo Clinic

    A Study Of Brentuximab Vedotin Combined With Nivolumab For Relapsed Or Refractory Hodgkin Lymphoma ... nivolumab in patients with relapsed or refractory ...

  5. Clinical trials - Oncology (Medical)

    Giving nivolumab with the usual chemotherapy may work better than the usual chemotherapy alone in treating patients with nasopharyngeal cancer. Perfusion ...

  6. Clinical trials - Oncology (Medical)

    Giving nivolumab with the usual chemotherapy may work better than the usual chemotherapy alone in treating patients with nasopharyngeal cancer. Perfusion ...

  7. A Study Of BMS-986340 In Combination With Nivolumab, Gemcitabine And Nab-paclitaxel In The First Line Setting Of Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    A Study Of BMS-986340 In Combination With Nivolumab, Gemcitabine And Nab-paclitaxel In The First Line Setting Of Metastatic Pancreatic Adenocarcinoma.

  8. A Study To Compare Standard Therapy To Treat Hodgkin Lymphoma To The Use Of Two Drugs, Brentuximab Vedotin And Nivolumab - Mayo Clinic

    The purpose of this study is to compare the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) in ...

  9. A Study In Treating Patients With Kidney Cancer Undergoing Nephrectomy Comparing PERioperative Nivolumab Vs. Observation - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Giving nivolumab before nephrectomy may make the ...

  10. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib And Nivolumab) To Treat Patients With Advanced Melanoma Or Squamous Cell Head And Neck Cancer, An ImmunoMATCH Pilot Study - Mayo Clinic

    ... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. Participation eligibility. Participant eligibility includes age, gender ...